Vericiguat, a key component of Loncom Pharma's Cardiovascular APIS, contributes to the development of cardiovascular medications, enhancing cardiac function and well-being for patients.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
